Kidney Failure, Chronic Clinical Trial
Official title:
Institutional Review Board of the Cardinal Tien Hospital
Aim. To investigate the effect of an intradialytic aerobic and resistance cycling exercise
program (IARCEP) on depression, fatigue, and quality of life (QOL) in end-stage renal disease
(ESRD) patients receiving haemodialysis, and further determine the effect of mediation
through self-efficacy and resilience in patients receiving the IARCEP.
Background. Depression and fatigue are common in ESRD patients undergoing haemodialysis,
which negatively affects their QOL. Exercise can mitigate this effect. Patient's
self-efficacy and resilience may be crucial mediators in exercise.
Design. This study was a randomised controlled trial. Method. Seventy-six participants were
randomly assigned to either a control or exercise group. Both groups received routine care;
whereas the exercise group participated the 3- months IARCEP. Data were collected at
baseline, the first, second, and third months, over a 14 months in 2013-2014.
According to the United States Renal Data System (2015), in 2013, 88.2% of all incident cases
of ESRD involved renal replacement therapy with haemodialysis, ESRD is highly prevalent in
Taiwan, with 2,902 cases per million people; 89.7% of cases in 2012 involved maintenance
haemodialysis treatment as the renal replacement therapy. Patients generally receive
haemodialysis 3 days per week, and each session generally takes 4 hr. Beginning dialysis
induces multiple physical and psychological stressors in patients. In particular, the
importance of intervention programs improving psychosocial function should be noted
considering disease and its long-term treatment. High depression and fatigue are crucial for
consideration in the global care of dialysis patients because these factors are associated
with mortality. A significant correlation exists between reduced physical activity and
increased depression or fatigue; with decreased activity, muscle strength decreases, which
exacerbates depression and fatigue.
Depression is the most common psychosocial problem observed in ESRD patients undergoing
haemodialysis, with a prevalence between 27.9% and 40.2% associated with a high risk of
hospitalisation and prolonged hospital stay, reduced quality of life (QOL), decreased
adherence to dialysis prescriptions, and increased medical comorbidity.
Fatigue is another critical concern caused by haemodialysis; ESRD patients receiving
haemodialysis have reduced red blood cell production, thus causing fatigue, the prevalence of
which ranges between 53% and 97%. Fatigue has a negative effect on the physical function,
ability to perform daily activities, QOL, and even survival of patients. QOL is the
subjective perception of an illness and corresponding treatment regarding physical,
psychological, and social well-being; however, QOL serves as a prognostic measure and
predictor of survival. ESRD patients receiving haemodialysis have a lower QOL than do other
patients with other chronic illnesses and general population. Lower health-related QOL is
associated with higher rates of hospitalisation and lower rates of survival among patients
undergoing haemodialysis. Therefore, identifying effective interventions to assist ESRD
patients receiving haemodialysis in managing their physical, psychological, and social
problems is critical.
Regular exercise could improve general health in many chronically ill patients. Planned
exercise programs are nonpharmacological interventions that can safely and effectively
improve depression, fatigue, and QOL. For ESRD patients undergoing haemodialysis, many
previous studies have shown that exercise decreases fatigue and depression, and improves QOL.
Accordingly, an intradialytic exercise program should be considered as a possible therapeutic
approach for improving fatigue, depression, and QOL in ESRD populations and should be
encouraged by and performed in haemodialysis centres. Although the benefits of related
exercise programs are known, an effective intradialytic exercise program for routine therapy
has not yet been developed. Few previous studies have implemented exercise programs to
examine the effects of psychological factors and QOL on patients receiving haemodialysis in
Taiwan.
Exercise self-efficacy is a crucial mediator of health behaviour. Self-efficacy is a key
construct in social-cognitive theory, in which personal beliefs correspond to an individual's
perceived ability to successfully perform specific tasks and activities. Pertaining to
beliefs in a person's ability to manage prospective situations, self-efficacy beliefs focus
on mediating change in individual behaviours. Thus, self-efficacy has a mediating effect on
depression resulting from stressful events. Self-efficacy as a mediator complements family
and healthcare provider support in diminishing the negative impact of depression in
haemodialysis patients. Relevantly, resilient people tend to have apparent adaptive
behaviours, particularly those related to somatic health. Resilience specifically refers to
smooth and rapid recovery from setbacks that may occur in a person's life. As such,
psychological resilience is considered a protective mechanism that operates in the presence
of negative stressors. People who are maladaptive with low competence and low adversity score
lower on these measures than resilient and competent groups do. Exercise self-efficacy,
resilience, and exercise behaviour are interrelated. Self-efficacy may motivate people to
perform their physical activity. However, the true effect of exercise programs fails to
account for the mediating effects of exercise self-efficacy and resilience.
Purpose Statements The purpose of this study was to investigate the effect of an
intradialytic aerobic and resistance cycling exercise program (IARCEP) on depression,
fatigue, and QOL in ESRD patients receiving haemodialysis, and to further determine the
effect of mediation through exercise self-efficacy and resilience in patients receiving the
IARCEP.
METHODS Research Design and Participants This study adopted a randomised controlled trial
design. ESRD participants were recruited from a haemodialysis centre in an 872-bed regional
hospital in Northern Taiwan. Data were collected over a 14 months in 2013-2014. The exercise
group received routine nursing care in addition to the IARCEP for 3 months. The control group
received only routine care in the same study period. A randomisation procedure was performed
outside of the study site by two nurse researchers. Permuted-block randomisation, for which
every block comprised four patients, was adopted to balance the number of patients in the
exercise and control groups. A randomisation list was drawn using random computer-generated
sequences. Information regarding these sequences was separately placed in opaque, sealed
envelopes to ensure that the participants were randomly allocated to the exercise or control
group. Outcomes were repeatedly measured four times at baseline and the first, second, and
third months.
Intradialytic aerobic and resistance cycling exercise program (IARCEP) An exercise program
brochure for the IARCEP was made available to the exercise group participants to ensure that
stationary cycling would be performed appropriately. A horizontal electromagnetic cycle
ergometer (Medical Exercise Peddler 3000, Medi-Bike, Taiwan) was used for the participants'
cycling performance. The exercise was performed during the first 2 hr of each haemodialysis
session (30 min per session, 3 sessions per week for 3 months). All participants were
assessed for cardiac and other medical contraindications to exercise by using PAR-Q.
Participants were required to perform stationary cycling at an intensity of 11-13 out of 20,
corresponding to the rate of perceived exertion on the Borg scale, whereby the intensity was
65%-85% of the participant's maximal capacity, representing the level at which cardiovascular
health can be maintained. Exercise was paused when the participants had systolic blood
pressure over 180 mmHg, diastolic blood pressure over 95 mmHg, heartbeat under 60 beats/min,
or pulse oxyhaemoglobin saturation (SpO2) under 88%. The participants' cardiac rhythm was
continuously monitored. Blood pressure and SpO2 was also measured every 5 min. The criteria
for interrupting exercise included physical exhaustion, chest pain, dyspnoea, dizziness, and
significant instabilities in heartbeat or blood pressure. Immediately following exercise, the
participants were assisted with removing the stationary cycling gear to adopt a comfortable
position for the immediate assessment of blood pressure, heart rate, and SpO2. Participants
were included in the subsequent analysis if they performed the aforementioned exercise
procedure at least 10 times per month.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03246984 -
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
|
N/A | |
Completed |
NCT02922361 -
Spending and Outcomes for Complex Medicare Advantage Patients
|
||
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Completed |
NCT01933789 -
Improving Communication About Serious Illness
|
N/A | |
Completed |
NCT01922843 -
A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
|
Phase 2 | |
Completed |
NCT01930396 -
Use of Tinzaparin for Anticoagulation in Hemodialysis
|
Phase 4 | |
Not yet recruiting |
NCT01674660 -
Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients
|
N/A | |
Completed |
NCT01209403 -
Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
|
Phase 4 | |
Not yet recruiting |
NCT01157260 -
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Completed |
NCT00534144 -
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
|
Phase 1 | |
Completed |
NCT00528788 -
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
Phase 4 | |
Completed |
NCT00226902 -
Vascular Reactivity in Kidney Disease Patients
|
N/A | |
Completed |
NCT00382044 -
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
|
N/A | |
Recruiting |
NCT00235287 -
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00224081 -
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
|
Phase 4 | |
Completed |
NCT00071214 -
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
|
Phase 3 | |
Completed |
NCT00049907 -
Cardiac and Renal Disease Study (CARDS)
|
N/A | |
Completed |
NCT00006297 -
Risk Factors for CV Disease in a Dialysis Cohort
|
N/A |